Cowen and Company’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
CCM
EAM
B
Cowen and Company's GH Position: Q4 2024 in Review
Cowen and Company sold out of Guardant Health (GH) in Q4 2024, closing a stake of 2,000 shares — an estimated $45.9K sold.
Cowen and Company first reported a position in GH in Q3 2022 and held it in 3 quarters. The position peaked at $513K in Q3 2022. 297 funds tracked by Wall St. Rank hold GH as of Q4 2024.
- Cowen and Company reported no remaining Guardant Health position as of Q4 2024 after selling out during the quarter.
- Cowen and Company sold 2,000 Guardant Health shares in Q4 2024, an estimated $45.9K.
- Cowen and Company first reported a position in Guardant Health in Q3 2022 and held it in 3 quarters.
- Cowen and Company's Guardant Health position peaked at $513K in Q3 2022.
- 297 funds tracked by Wall St. Rank held Guardant Health as of Q4 2024.
Based on Cowen and Company's 13F filing for Q4 2024.